SCHEMBL5698694

SCHEMBL5698694

CS(=O)(=O)c1ccc(-c2[nH]cnc2-c2ccc(F)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 3/20 0.61
MAPK11 Q15759 2/20 0.61
MAPK13 O15264 1/20 0.61
RAF1 P04049 1/20 0.61
MAPK9 P45984 1/20 0.61
MAPK12 P53778 1/20 0.61
PTGS2 P35354 14/20 0.60
PTGS1 P23219 5/20 0.60
BRD4 O60885 1/20 0.56
ALDH1A1 P00352 1/20 0.54
ALOX5 P09917 1/20 0.54
CSNK1A1 P48729 1/20 0.54
CSNK1D P48730 1/20 0.54
CSNK1E P49674 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CSNK1A1L Q8N752 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133402 0.87 KDM4E (0.67) MAPK14PTGS2PTGS1
SCHEMBL10992179 0.84 MAPK14 (0.83) MAPK14MAPK11MAPK13RAF1MAPK9
Hydrochloric Acid SCHEMBL30023185 0.82 MAPK14 (0.80) MAPK14MAPK11MAPK13RAF1MAPK9
SCHEMBL7087770 0.77 MAPK14 (0.67) MAPK14MAPK11MAPK13RAF1MAPK9
SCHEMBL6423292 0.76 MAPK14 (1.00) MAPK14MAPK11MAPK13RAF1MAPK9
SCHEMBL4434902 0.76 MAPK14 (1.00) MAPK14MAPK11MAPK13RAF1MAPK9
SCHEMBL7083972 0.75 PTGS2 (0.75) MAPK14MAPK11PTGS2PTGS1ALDH1A1
SCHEMBL7395459 0.75 PTGS2 (0.74) PTGS2PTGS1
SCHEMBL6470141 0.75 PTGS2 (0.74) PTGS2PTGS1
SCHEMBL10355431 0.75 PTGS2 (0.46) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed